Management ChangeSep 2, 2026, 06:08 AM
Oncology Institute Director Brad Hively Not Seeking Re-election
AI Summary
On September 1, 2026, Brad Hively informed Starling Oncology, Inc. of his decision not to stand for re-election to the Board of Directors at the 2027 annual meeting. He will continue to serve as a director until the meeting but has stepped down immediately as Vice Chairman and from all Board committees, including the Compliance Committee. The company stated that Hively's decision is not due to any disagreements regarding company operations, policies, or practices.
Key Highlights
- Brad Hively will not stand for re-election to the Board of Directors at the 2027 annual meeting.
- Hively will continue to serve as a director until the 2027 annual meeting.
- Effective immediately, Hively resigns as Vice Chairman of the Board.
- Hively also resigns from the Compliance Committee and all other Board committees.
Price Impact
More from TOI